Free Trial

agilon health (NYSE:AGL) Sets New 1-Year Low - Here's Why

agilon health logo with Medical background

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $2.43 and last traded at $2.43, with a volume of 39526 shares trading hands. The stock had previously closed at $2.52.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Citigroup reiterated a "sell" rating and set a $2.50 target price (down from $7.00) on shares of agilon health in a research report on Tuesday. Royal Bank of Canada reaffirmed an "outperform" rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a report on Friday, August 9th. Benchmark reaffirmed a "buy" rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Finally, Bank of America cut shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective for the company. in a research note on Wednesday, October 2nd. Three equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $7.81.

Get Our Latest Research Report on AGL

agilon health Stock Down 2.4 %

The business has a 50-day moving average price of $3.54 and a 200 day moving average price of $5.11. The stock has a market capitalization of $1.01 billion, a P/E ratio of -3.26 and a beta of 0.54. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business earned ($0.04) earnings per share. agilon health's quarterly revenue was up 38.7% compared to the same quarter last year. On average, equities analysts expect that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Insider Buying and Selling at agilon health

In related news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of AGL. J.Safra Asset Management Corp grew its holdings in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock worth $27,000 after purchasing an additional 3,625 shares during the last quarter. City State Bank bought a new stake in shares of agilon health during the third quarter valued at approximately $52,000. CWM LLC boosted its holdings in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new position in agilon health in the second quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC purchased a new position in agilon health during the 1st quarter worth $65,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

→ Watch this before it gets removed (From Porter & Company) (Ad)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines